T65.5X2 Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm

Name of the Condition

• Toxic Effect of Nitroglycerin and Other Nitric Acids and Esters, Intentional Self-Harm

Summary

This condition describes adverse health effects resulting from intentional self-harm involving nitroglycerin or other nitric acids and esters. These substances, known for their vasodilatory properties, can cause systemic toxicity when absorbed in excessive amounts, primarily affecting cardiovascular and neurological systems.

Causes

The toxic effect is caused by intentional self-harm involving nitroglycerin or related nitric acids and esters, typically through ingestion, inhalation, or dermal contact. Common sources include pharmaceutical preparations (e.g., for angina) or industrial chemicals. Intentional overdose or misuse of these substances leads to poisoning.

Risk Factors

• Intentional overdose of nitroglycerin-containing medications.
• Access to nitroglycerin or related compounds for self-harm.
• History of self-harm or suicidal behavior.
• Misuse of topical or oral nitroglycerin products.

Symptoms

• Severe headache, dizziness, or lightheadedness.
• Profound hypotension (low blood pressure) and tachycardia (rapid heart rate).
• Nausea, vomiting, and abdominal pain.
• Flushing, sweating, and skin irritation.
• Syncope (fainting), seizures, or cardiovascular collapse in severe cases.

Diagnosis

Diagnosis is based on clinical presentation, history of intentional exposure, and laboratory findings. Clinical assessment includes evaluating symptoms of vasodilation, hypotension, and potential methemoglobinemia. Toxicology screening may confirm exposure to nitroglycerin or related compounds.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further absorption. Interventions may include supportive care, intravenous fluids, vasopressors for hypotension, and methemoglobinemia treatment if present. Decontamination measures (e.g., activated charcoal) may be considered if ingestion occurred recently.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Mild cases may resolve with supportive care, while severe cases can lead to complications like cardiovascular collapse. Follow-up includes monitoring for delayed effects and addressing underlying mental health concerns.

Complications

• Cardiovascular collapse or shock.
• Methemoglobinemia, leading to tissue hypoxia.
• Neurological damage from prolonged hypotension.
• Organ failure due to systemic toxicity.

Lifestyle & Prevention

Prevention involves secure storage of nitroglycerin and related substances, especially in households with at-risk individuals. Education on proper medication use and access to mental health resources may reduce intentional self-harm risks.

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to nitroglycerin or related compounds is suspected, or if symptoms like severe dizziness, hypotension, or altered consciousness occur.

Tips for Medical Coders

Document the intent (intentional self-harm) and clinical details to support coding. Ensure the code T65.5X2 is used when the toxic effect is due to intentional self-harm. Include details on exposure route, severity, and any associated complications for accurate coding.